Intratumoural microbiota: from theory to clinical applicationarticle Published on 2023-06-282024-09-05 Journal: Cell Communication and Signaling : CCS [Category] update2024, [키워드] anticancer treatment Intratumoural bacteria tumorigenesis [DOI] 10.1186/s12964-023-01134-z PMC 바로가기 [Article Type] article
Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination고형암 환자는 SARS-CoV-2 백신 접종 후 적절한 면역원성과 낮은 중증 부작용 발생률 달성Article Published on 2022-07-012022-09-11 Journal: Future Oncology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제, [키워드] A significant reduction active treatment Adverse adverse events anti-SARS-CoV-2 S1 IgG antibody antibody level antibody levels anticancer anticancer treatment cancer patient Cancer patients Complete Course COVID-19 disease event healthy controls Immune checkpoint inhibitor Immune checkpoint inhibitors immunogenicity Mild mRNA mRNA-based mRNA-based vaccination mRNA-based vaccine participant Patient patients Prevent receiving Result SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose Seroconversion seroconversion rate serum severe adverse event severe COVID-19 disease Solid solid cancer therapy Treatment vaccination [DOI] 10.2217/fon-2022-0148 PMC 바로가기 [Article Type] Article
Ninety-day mortality and clinical outcomes of patients with solid tumours and COVID-19 infection during the first pandemic outbreak in Catalonia, Spain: A multicentre retrospective studyMulticenter Study Published on 2022-04-152023-07-07 Journal: International journal of cancer [Category] COVID19(2023년), [키워드] anticancer treatment COVID-19 Mortality outbreak Solid tumours [DOI] 10.1002/ijc.33909 [Article Type] Multicenter Study
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in ItalyResearch article Published on 2021-11-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] SARS, 치료법, [키워드] administration antibodies antibody anticancer anticancer treatment baseline BNT162b2 Cancer cancer patient Cancer patients cancer progression composed conducted consecutive patient control group coronavirus disease COVID-19 COVID-19 antibody COVID-19 infection COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine evaluate evaluated Factor GRADE healthy volunteers high risk IgG IgG titer immunogenic Italy Male sex median median age metastatic disease Patient prospective observational study receive reported Result RNA-1273 safety profile SARS-CoV-2 second dose secondary Seroconversion Seropositivity serum sample Side-effects significantly lower solid cancer solid tumour the vaccine therapy Treatment tumour two-dose regimen vaccination Vaccine vaccine dose were excluded [DOI] 10.1016/j.ejca.2021.08.035 [Article Type] Research article
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT studyObservational Study Published on 2020-11-012023-07-12 Journal: ESMO open [Category] SARS, [키워드] anticancer treatment cancer care Chemotherapy COVID-19 pandemic [DOI] 10.1136/esmoopen-2020-000883 PMC 바로가기 [Article Type] Observational Study
Special Issues Encountered When Cancer Patients Confront COVID-19Oncology Published on 2020-08-072022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] anticancer anticancer treatment Cancer cancer patient Cancer patients Clinical data COVID-19 COVID-19 diagnosis Diagnosis diagnostic Evidence global pandemic help hospital incidence issue Mortality non-infected oncologist Patient Prognosis Treatment [DOI] 10.3389/fonc.2020.01380 PMC 바로가기 [Article Type] Oncology